Advaxis Presents Updated Clinical Data from Ongoing Phase 1/2 Trial of ADXS-503 in NSCLC and Upcoming Milestones

NEXT STORY
Pliant Therapeutics Highlights Recent Developments for Lead Program PLN-74809 and Expected 2022 Milestones
PREV STORY
Antares Pharma Announces Positive Results From Phase I Study For ATRS-1902 For Adrenal Crisis Rescue
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Skylight Health Completes Acquisition of APEX Medical in Colorado with $2.5 Million in Revenue and Positive EBITDA

author_avatar
NASDAQ Market News

Forty Seven Inc. to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 28, 2019

author_avatar
NASDAQ Market News

Novartis Cosentyx® first to show efficacy in all key manifestations of psoriatic arthritis

author_avatar
NASDAQ Market News